The human body employs a sophisticated array of antioxidants to combat oxidative stress
certain variants in genes controlling appetite and metabolic pathways may influence how your digestive system responds to GLP-1 therapy, which is why PlexusDx offers the Precision Peptide Genetic Test to understand your individual response
Association of donanemab treatment with exploratory plasma biomarkers in early symptomatic Alzheimer disease: a secondary analysis of the TRAILBLAZER-ALZ randomized clinical trial
This is clinical education, not medical advice, and nothing here should be read as a treatment recommendation, protocol, or dosing guidance
Daniel Drucker and his team at the Lunenfeld-Tanenbaum Research Institute in Toronto, are studying how glucagon-like peptide-1 (GLP-1), a hormone that helps regulate blood sugar levels and other biological functions, reduces inflammation and improves the health of blood vessels, the liver, and kidneys